European_wide_survey_of_carbapenem__and_or_colistin_resistant_Enterobacteriaceae-sc-6259
European_wide_survey_of_carbapenem__and_or_colistin_resistant_Enterobacteriaceae
This study will use whole genome sequencing (WGS) data from Klebsiella pneumoniae and Escherichia coli isolates collected during the 2019 European-wide survey of carbapenem- and/or colistin-resistant Enterobacteriaceae. Isolates were collected from hospitals and their associated clinical microbiology laboratories in 37 countries during a six-month period. Both resistant and comparator susceptible isolates were collected. The WGS data will be used to analyse the population structure, with particular emphasis on the identification of high-risk clones. It will also be used to determine the prevalence, distribution and transmission dynamics of key resistance and virulence markers.  This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
This study will use whole genome sequencing (WGS) data from Klebsiella pneumoniae and Escherichia coli isolates collected during the 2019 European-wide survey of carbapenem- and/or colistin-resistant Enterobacteriaceae. Isolates were collected from hospitals and their associated clinical microbiology laboratories in 37 countries during a six-month period. Both resistant and comparator susceptible isolates were collected. The WGS data will be used to analyse the population structure, with particular emphasis on the identification of high-risk clones. It will also be used to determine the prevalence, distribution and transmission dynamics of key resistance and virulence markers.